Changes in the intestinal absorption mechanism of icariin in the nanocavities of cyclodextrins

References

• FrewSESammutSMShoreAFChinese health biotech and the billion-patient marketNature Biotechnol2008261375318183014
   PubMed Web of Science ®Google Scholar
• ZhangGQinLShiYEpimedium-derived phytoestrogen flavonoids exert beneficial effect on preventing bone loss in late postmenopausal women: a 24-month randomized, double-blind and placebo-controlled trialJ Bone Miner Res20072271072107917419678
   PubMed Web of Science ®Google Scholar
• MakarovaMNPozharitskayaONShikovANTesakovaSVMakarovVGTikhonovVPEffect of lipid-based suspension of Epimedium koreanum Nakai extract on sexual behavior in ratsJ Ethnopharmacol2007114341241617890032
   PubMed Web of Science ®Google Scholar
• MengFHLiYBXiongZLJiangZMLiFMOsteoblastic proliferative activity of Epimedium brevicornum MaximPhytomedicine200512318919315830840
   PubMed Web of Science ®Google Scholar
• PanYZhangWYXiaXKongLDEffects of icariin on hypothalamic-pituitary-adrenal axis action and cytokine levels in stressed Sprague-Dawley ratsBiol Pharm Bull200629122399240317142971
   PubMed Web of Science ®Google Scholar
• PanYKongLXiaXZhangWXiaZJiangFAntidepressant-like effect of icariin and its possible mechanism in micePharmacol Biochem Behav200582468669416380159
   PubMed Web of Science ®Google Scholar
• HuangXZhuDLouYA novel anticancer agent, icaritin, induced cell growth inhibition, G1 arrest and mitochondrial transmembrane potential drop in human prostate carcinoma PC-3 cellsEur J Pharmacol20075641–3263617382317
   PubMed Web of Science ®Google Scholar
• MoSFZhouFLvYZHuQHZhangDMKongLDHypouricemic action of selected flavonoids in mice: structure-activity relationshipsBiol Pharm Bull20073081551155617666819
   PubMed Web of Science ®Google Scholar
• LiFGongQHWuQLuYFShiJSIcariin isolated from Epimedium brevicornum Maxim attenuates learning and memory deficits induced by d-galactose in ratsPharmacol Biochem Behav201096330130520566405
   PubMed Web of Science ®Google Scholar
• XinZCKimEKLinCSEffects of icariin on cGMP-specific PDE5 and cAMP-specific PDE4 activitiesAsian J Androl200351151812646997
   PubMed Web of Science ®Google Scholar
• ZhangYPXuWLiNLC-MS-MS method for simultaneous determination of icariin and its active metabolite icariside II in human plasmaChromatographia2008683–4245250
   Web of Science ®Google Scholar
• XuWZhangYYangMLC-MS/MS method for the simultaneous determination of icariin and its major metabolites in rat plasmaJ Pharm Biomed Anal200745466767217706393
   PubMed Web of Science ®Google Scholar
• ChengSQiuFWangSHeJHPLC analysis and pharmacokinetics of icariin in ratsJ Sep Sci20073091307131217623472
   PubMed Web of Science ®Google Scholar
• ChaoJWangHZhaoWZhangMZhangLInvestigation of the inclusion behavior of chlorogenic acid with hydroxypropyl-β-cyclodextrinInt J Biol Macromol201250127728222115718
   PubMed Web of Science ®Google Scholar
• LoftssonTHreinsdottirDMassonMEvaluation of cyclodextrin solubilization of drugsInt J Pharm20053021–2182816099118
   PubMed Web of Science ®Google Scholar
• RajewskiRAStellaVJPharmaceutical applications of cyclodextrins. 2. In vivo drug deliveryJ Pharm Sci19968511114211698923319
   PubMed Web of Science ®Google Scholar
• LiJXiaoHLiJZhongYDrug carrier systems based on water-soluble cationic beta-cyclodextrin polymersInt J Pharm2004278232934215196638
   PubMed Web of Science ®Google Scholar
• LiuJQiuLGaoJJinYPreparation, characterization and in vivo evaluation of formulation of baicalein with hydroxypropyl-beta-cyclodextrinInt J Pharm20063121–213714316459034
   PubMed Web of Science ®Google Scholar
• KanoKKitagishiHTanakaSCharacterization of an inclusion complex of 5,10,15,20-tetrakis(4-sulfonatophenyl)-porphinato iron and an O-methylated β-cyclodextrin dimer having a pyridine linker and its related complexes in aqueous solutionJ Incl Phenom Macrocycl Chem2006561–26974
   Web of Science ®Google Scholar
• GouldSScottRC2-Hydroxypropyl-beta-cyclodextrin (HP-beta-CD): a toxicology reviewFood Chem Toxicol200543101451145916018907
   PubMed Web of Science ®Google Scholar
• CastronuovoGNiccoliMThermodynamics of inclusion complexes of natural and modified cyclodextrins with propranolol in aqueous solution at 298 KBioorg Med Chem200614113883388716480882
   PubMed Web of Science ®Google Scholar
• ChallaRAhujaAAliJKharRKCyclodextrins in drug delivery: an updated reviewAAPS Pharm Sci Tech200562E329357
   PubMed Web of Science ®Google Scholar
• BrewsterMELoftssonTThe use of chemically modified cyclodextrins in the development of formulations for chemical delivery systemsPharmazie20025729410111878196
   PubMed Web of Science ®Google Scholar
• DavisMEBrewsterMECyclodextrin-based pharmaceutics: past, present and futureNat Rev Drug Discov20043121023103515573101
   PubMed Web of Science ®Google Scholar
• DucheneDWouessidjeweDPonchelGCyclodextrins and carrier systemsJ Control Release1999621–226326810518659
   PubMed Web of Science ®Google Scholar
• IrieTUekamaKPharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluationJ Pharm Sci19978621471629040088
   PubMed Web of Science ®Google Scholar
• ArimaHYunomaeKHirayamaFUekamaKContribution of P-glycoprotein to the enhancing effects of dimethyl-beta-cyclodextrin on oral bioavailability of tacrolimusJ Pharmacol Exp Ther2001297254755511303042
   PubMed Web of Science ®Google Scholar
• Meyer dos SantosSWeberCCFrankeCMullerWEEckertGPCholesterol: Coupling between membrane microenvironment and ABC transporter activityBiochem Biophys Res Commun2007354121622117223079
   PubMed Web of Science ®Google Scholar
• FenyvesiFFenyvesiESzenteLP-glycoprotein inhibition by membrane cholesterol modulationEur J Pharm Sci2008344–523624218539442
   PubMed Web of Science ®Google Scholar
• CaiCZhuHChenJOverexpression of caveolin-1 increases plasma membrane fluidity and reduces P-glycoprotein function in Hs578T/DoxBiochem Biophys Res Commun2004320386887415240128
   PubMed Web of Science ®Google Scholar
• CalabroMLTommasiniSDonatoPThe rutin/beta-cyclodextrin interactions in fully aqueous solution: spectroscopic studies and biological assaysJ Pharm Biomed Anal20053651019102715620528
   PubMed Web of Science ®Google Scholar
• KunesMSvobodaZKvetinaJHeroutVHerinkJBajgarJIntestinal single-pass in situ perfusion technique in rat: the influence of L-carnitine on absorption of 7-methoxytacrineBiomed Pap Med Fac Univ Palacky Olomouc Czech Repub2005149243343516601805
   PubMedGoogle Scholar
• NornooAOZhengHLopesLBJohnson-RestrepoBKannanKReedROral microemulsions of paclitaxel: in situ and pharmacokinetic studiesEur J Pharm Biopharm200971231031718793723
   PubMed Web of Science ®Google Scholar
• BelliSElsenerPMWunderli-AllenspachHKramerSDCholesterol- mediated activation of P-glycoprotein: distinct effects on basal and drug-induced ATPase activitiesJ Pharm Sci20099851905191818937360
   PubMed Web of Science ®Google Scholar
• HiguchiTConnorsKPhase solubility techniquesAdvances in Analytical Chemistry and Instrumentation19657117212
   Google Scholar
• YangHParniakMAIsaacsCEHillierSLRohanLCCharacterization of cyclodextrin inclusion complexes of the anti-HIV non-nucleoside reverse transcriptase inhibitor UC781AAPS J200810460661319089644
   PubMed Web of Science ®Google Scholar
• Badr-EldinSMElkheshenSAGhorabMMInclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluationEur J Pharm Biopharm200870381982718655829
   PubMed Web of Science ®Google Scholar
• CappelloBDi MaioCIervolinoMMiroAImprovement of solubility and stability of valsartan by hydroxypropyl-beta-cyclodextrinJ Incl Phenom Macrocycl Chem2006543–4289294
   Web of Science ®Google Scholar
• SchneiderHJHacketFRudigerVIkedaHNMR studies of cyclodextrins and cyclodextrin complexesChem Rev19989851755178611848948
   PubMed Web of Science ®Google Scholar
• de AraujoMVVieiraEKSilva LazaroGSulfadiazine/hydroxypropyl-beta-cyclodextrin host-guest system: Characterization, phase-solubility and molecular modelingBioorg Med Chem200816105788579418434167
   PubMed Web of Science ®Google Scholar
• JullianCOrosteguisTPerez-CruzFSanchezPMendizabalFOlea-AzarCComplexation of morin with three kinds of cyclodextrin. A thermodynamic and reactivity studySpectrochim Acta A Mol Biomol Spectrosc200871126927518262835
   PubMed Web of Science ®Google Scholar
• SalphatiLChildersKPanLTsutsuiKTakahashiLEvaluation of a single-pass intestinal-perfusion method in rat for the prediction of absorption in manJ Pharm Pharmacol20015371007101311480535
   PubMed Web of Science ®Google Scholar
• EckfordPDSharomFJABC efflux pump-based resistance to chemotherapy drugsChem Rev200910972989301119583429
   PubMed Web of Science ®Google Scholar
• ZhouSLimLYChowbayBHerbal modulation of P-glycoproteinDrug Metab Rev20043615710415072439
   PubMed Web of Science ®Google Scholar
• TeodoriEDeiSScapecchiSGualtieriFThe medicinal chemistry of multidrug resistance (MDR) reversing drugsFarmaco200257538541512058813
   PubMedGoogle Scholar
• DaiFLiuWEnhanced gene transfection and serum stability of polyplexes by PDMAEMA-polysulfobetaine diblock copolymersBiomaterials201132262863820888634
   PubMed Web of Science ®Google Scholar
• CollnotEMBaldesCWempeMFMechanism of inhibition of P-glycoprotein mediated efflux by vitamin E TPGS: influence on ATPase activity and membrane fluidityMol Pharm20074346547417367162
   PubMed Web of Science ®Google Scholar